Prognostic significance of WBC, age, and cytogenetics in patients with core binding factor acute myeloid leukemia (CBF-AML): A comparative study from the French AML Intergroup.

被引：0
|
作者：
Delaunay, J
Leblanc, T
Blaise, D
Fenaux, P
Huguet-Rigal, F
Witz, F
Pigneux, A
Thomas, X
Auvrignon, A
Colombat, P
Lioure, B
Van den Akker, J
Mugneret, F
Bastard, C
Dastugue, N
Castaigne, S
Reiffers, J
Leverger, G
Harousseau, JL
Dombret, H
机构：
[1] Hop St Louis, Paris, France
[2] IPC, Marseille, France
[3] Hop Claude Huriez, Lille, France
[4] Hop Purpan, Toulouse, France
[5] Hop Brabois, Nancy, France
[6] Hop Haut Leveque, Bordeaux, France
[7] Hop Edouard Herriot, Lyon, France
[8] Hop Trousseau, F-75571 Paris, France
[9] Hop Bretonneau, Tours, France
[10] Hop Hautepierre, Strasbourg, France
[11] Hop St Antoine, F-75571 Paris, France
[12] Hop Bocage, Dijon, France
[13] Ctr Henri Becquerel, F-76038 Rouen, France
[14] Hop Andre Mignot, Versailles, France
[15] Hop Hotel Dieu, Nantes, France
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2960
引用
收藏
页码：748A / 748A
页数：1
相关论文
共 50 条
  • [21] PROGNOSTIC SIGNIFICANCE OF FLT3/ITD MUTATION AND ABCB1 GENE POLYMORPHISMS IN CORE BINDING FACTOR (CBF)-ACUTE MYELOID LEUKEMIA (AML)
    Kim, Y. K.
    Kim, H. N.
    Lee, I. K.
    Bang, S. M.
    Kim, H. J.
    Jo, D. Y.
    Won, J. H.
    Kwak, J. Y.
    Park, M. R.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    Kim, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 120 - 121
  • [22] Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.
    Baer, MR
    O'Loughlin, KL
    Minderman, H
    Sait, SN
    Flood, JJ
    Sorci, JJ
    Stewart, CC
    BLOOD, 1999, 94 (10) : 64A - 64A
  • [23] The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations.
    Appelbaum, FR
    Kopecky, KJ
    Slovak, ML
    Gundacker, HM
    Tallman, M
    Kim, H
    Dewald, GW
    Estey, E
    Kantarjian, H
    Pierce, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 563S - 563S
  • [24] High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)
    Libing Wang
    Lei Gao
    Sheng Xu
    Shenglan Gong
    Min Liu
    Huiying Qiu
    Xiaoqian Xu
    Xiong Ni
    Li Chen
    Shuqing Lu
    Jie Chen
    Xianmin Song
    Weiping Zhang
    Jianmin Yang
    Xiaoxia Hu
    Jianmin Wang
    Annals of Hematology, 2014, 93 : 1685 - 1694
  • [25] High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)
    Wang, Libing
    Gao, Lei
    Xu, Sheng
    Gong, Shenglan
    Liu, Min
    Qiu, Huiying
    Xu, Xiaoqian
    Ni, Xiong
    Chen, Li
    Lu, Shuqing
    Chen, Jie
    Song, Xianmin
    Zhang, Weiping
    Yang, Jianmin
    Hu, Xiaoxia
    Wang, Jianmin
    ANNALS OF HEMATOLOGY, 2014, 93 (10) : 1685 - 1694
  • [26] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) WITH A PCR-NEGATIVE GRAFT WAS ASSOCIATED WITH A FAVORABLE OUTCOME FOR CORE-BINDING-FACTOR ACUTE MYELOID LEUKEMIA (CBF-AML)
    Nakasone, H.
    Izutsu, K.
    Wakita, S.
    Yamaguchi, H.
    Muramatsu-Kida, M.
    Usuki, K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 40 - 40
  • [27] Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype
    Marcault, Clemence
    Boissel, Nicolas
    Haferlach, Claudia
    Loschi, Michael
    Raynaud, Sophie
    Cluzeau, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : E199 - E205
  • [28] VARIANT ALLELE FREQUENCY KINETICS OF TYROSINE KINASE GENE MUTATIONS IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA (CBF-AML) UNDER TREATMENT WITH AND WITHOUT DASATINIB
    Agrawal, M.
    Jahn, N.
    Dolnik, A.
    Cocciardi, S.
    Schmalbrock, L. K.
    Blaette, T. J.
    Gaidzik, V.
    Luebbert, M.
    Fiedler, W.
    Fischer, T.
    Brossart, P.
    Wattad, M.
    Thol, F.
    Heuser, M.
    Ganser, A.
    Schlenk, R. F.
    Paschka, P.
    Doehner, H.
    Doehner, K.
    Bullinger, L.
    HAEMATOLOGICA, 2017, 102 : 204 - 205
  • [29] Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing
    Kim, Taehyung
    Moon, Joon Ho
    Ahn, Jae-Sook
    Tyndel, Marc S.
    Kim, Yeo-Kyeoung
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seunghyun
    Lee, Yoojin
    Sohn, Sang Kyun
    Min, Yoo Hong
    Cheong, June-Won
    Kim, Hyeoung-Joon
    Zhang, Zhaolei
    Kim, Dennis
    BLOOD, 2017, 130
  • [30] A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML):: a survey of 161 cases from the French AML Intergroup
    Nguyen, S
    Leblanc, T
    Fenaux, P
    Witz, F
    Blaise, D
    Pigneux, A
    Thomas, X
    Rigal-Huguet, F
    Lioure, B
    Auvrignon, A
    Fière, D
    Reiffers, J
    Castaigne, S
    Leverger, G
    Harousseau, JL
    Socié, G
    Dombret, H
    BLOOD, 2002, 99 (10) : 3517 - 3523
12345